Calculated based on number of publications stored in Pure and citations from Scopus
20112021

Research activity per year

Network

P. H. Jones

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • University of Texas at Austin
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Richard T. Lewis

  • University of Texas Health Science Center at Houston
  • University of Texas MD Anderson Cancer Center

External person

Sha Huang

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Jefferson W. Tilley

  • Hoffmann-La Roche Inc.

External person

Naphtali J. Reyna

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Jay Theroff

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Jason B. Cross

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Angela L. Harris

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Lexicon Genetics Incorporated
  • Department of Metabolism Research

External person

Alessia Petrocchi

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston
  • IRBM S.p.A.

External person

Jason P. Burke

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Connor A. Parker

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Carlo Toniatti

  • University of Texas MD Anderson Cancer Center
  • IRBM/Merck Research Laboratories
  • Merck
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • Center for Co-Clinical Trials
  • ORBIT (Oncology Research for Biologics and Immunotherapy Translation)
  • Department of Oncology
  • Department of Oncology
  • University of Texas Health Science Center at Houston
  • IRBM S.p.A.

External person

Michael J. Soth

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Barbara Czako

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Yimin Qian

  • Hoffmann-La Roche Inc.
  • Pharmaceutical Research and Early Drug Development

External person

Karin Conde-Knape

  • Hoffmann-La Roche Inc.

External person

Mario Cardozo

  • Nurix, Inc.
  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Norma Rogers

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Joseph R. Marszalek

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Institute of Applied Cancer Science and the Center for Co-Clinical Trials
  • Center for Co-Clinical Trials
  • Center for Co-Clinical Trials and Institute for Applied Cancer Science
  • University of Texas at Austin
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston
  • Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION)
  • Center for Co-Clinical Trials and Institute for Applied Cancer Science

External person

Rebbeca Taub

  • Hoffmann-La Roche Inc.
  • Via Pharmaceuticals Inc.

External person

Yonglin Ren

  • Hoffmann-La Roche Inc.
  • Pharmaceutical Research and Early Drug Development

External person

Fariborz Firooznia

  • Hoffmann-La Roche Inc.

External person

Ju Anne Yau

  • University of Texas MD Anderson Cancer Center

External person

Lida Qi

  • Hoffmann-La Roche Inc.

External person

Jennifer Greer

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Lexicon Genetics Incorporated

External person

Liang Guo

  • Hoffmann-La Roche Inc.

External person

Sung Sau So

  • Hoffmann-La Roche Inc.

External person

Nathan R. Scott

  • Hoffmann-La Roche Inc.

External person

Elisa de Stanchina

  • Memorial Sloan-Kettering Cancer Center

External person

Jeffrey J. Kovacs

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Wylie S. Palmer

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Dana Pfaffinger

  • University of Texas Health Science Center at Houston

External person

Sarah Johnson

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Baolian Liu

  • Hoffmann-La Roche Inc.

External person

Maria E. Di Francesco

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • University of Texas at Austin
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Jenny Tan

  • Hoffmann-La Roche Inc.

External person

Nancy Ellen Haynes

  • Hoffmann-La Roche Inc.

External person

Anjula Pamidimukkala

  • Hoffmann-La Roche Inc.

External person

Elisabetta Leo

  • National Institutes of Health
  • University of Texas MD Anderson Cancer Center
  • Babraham Research Campus
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • Laboratory of Molecular Pharmacology
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston
  • AstraZeneca

External person

Alfred Lammens

  • Proteros Biostructures GmbH

External person

Stephen Gabriel

  • Pharmaceutical Research and Early Drug Development

External person

Mary Geck Do

  • University of Texas MD Anderson Cancer Center

External person

Catherine Zwingelstein

  • Hoffmann-La Roche Inc.

External person

Adrian Wai Hing Cheung

  • Hoffmann-La Roche Inc.

External person

Robert A. Mullinax

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Center for Co-Clinical Trials
  • Lexicon Genetics Incorporated

External person

Hannah E. Shepard

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston

External person

Ryan C. Schoenfeld

  • Pharmaceutical Research and Early Drug Development

External person

Sherrie Pietranico-Cole

  • Hoffmann-La Roche Inc.

External person

Toni Whittard

  • Hoffmann-La Roche Inc.

External person

Adrian J. Fretland

  • Non-clinical Safety
  • Repare Therapeutics
  • National Institutes of Health
  • Drug Metabolism and Pharmacokinetics

External person

Matthew Lucas

  • Pharmaceutical Research and Early Drug Development

External person

Rama Kondru

  • Pharmaceutical Research and Early Drug Development

External person

Nakia D. Spencer

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Michelle Han

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Dramane Laine

  • Pharmaceutical Research and Early Drug Development

External person

Lin Zhang

  • Pharmaceutical Research and Early Drug Development

External person

Robert A. Goodnow

  • Hoffmann-La Roche Inc.

External person

Keith Mikule

  • Tesaro Biopharmaceuticals
  • TESARO Inc

External person

C. M. Rudin

  • Johns Hopkins
  • Johns Hopkins University School of Medicine
  • Memorial Sloan-Kettering Cancer Center
  • Johns Hopkins University
  • The University of Chicago
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Department of Oncology
  • Fox Chase Cancer Center
  • Cornell University
  • Thoracic Oncology Service
  • Molecular Chemistry and Pharmacology Program
  • Department of Medical Oncology
  • Department of Oncology
  • Department of Oncology
  • Case Western Reserve University
  • Weill Cornell Medical Center

External person

Gang Liu

  • University of Texas Health Science Center at Houston
  • University of Texas MD Anderson Cancer Center

External person

Achyutharao Sidduri

  • Pharmaceutical Research and Early Drug Development

External person

Arjun Narayanan

  • Pharmaceutical Research and Early Drug Development

External person

Rachid Hamid

  • Discovery Technology

External person

Stephan Krapp

  • Proteros Biostructures GmbH

External person

Weiya Yun

  • Hoffmann-La Roche Inc.

External person

Mushtaq Ahmad

  • Hoffmann-La Roche Inc.

External person

Nicholas Marcopulos

  • Hoffmann-La Roche Inc.

External person

Christopher S. Stevenson

  • Lung Cancer Initiative at Johnson and Johnson
  • Lung Cancer Initiative
  • Johnson & Johnson
  • Pharmaceutical Research and Early Drug Development

External person

Timothy P. Heffernan

  • University of Texas MD Anderson Cancer Center
  • Harvard University
  • Dana-Farber Cancer Institute
  • University of Texas MD Anderson Cancer Center
  • C4 Therapeutics
  • Institute for Applied Cancer Science
  • Center for Co-Clinical Trials
  • Belfer Institute for Applied Cancer Science
  • Department of Medical Oncology
  • Belfer Institute for Applied Cancer Science
  • Department of Medical Oncology
  • Institute of Applied Cancer Science and the Center for Co-Clinical Trials
  • Cornell University
  • Department of Medicine
  • University of Texas at Austin
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • University of Texas Health Science Center at Houston
  • C4 Therapeutics, Inc.

External person

Paul Gillespie

  • Department of Discovery Chemistry
  • Hoffmann-La Roche Inc.
  • Hoffmann-La Roche, Inc.

External person

Xi Shi

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • Institute for Applied Cancer Science
  • Center for Co-Clinical Trials
  • University of Texas Health Science Center at Houston

External person

Cristina M. Rondinone

  • Hoffmann-La Roche Inc.

External person

Pijus K. Mandal

  • M.D. Anderson Cancer Center
  • Department of Experimental Therapeutics
  • Dept. of Biology and Biochemistry
  • University of Texas MD Anderson Cancer Center
  • University of Houston
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • University of Texas Health Science Center at Houston

External person

Shiming Li

  • Hoffmann-La Roche Inc.

External person

Yun Chen

  • Discovery Technology

External person

Stuart Hayden

  • Hoffmann-La Roche Inc.

External person

Ruoqi Peng

  • Pharmaceutical Research and Early Drug Development

External person

Michelle Han

  • University of Texas MD Anderson Cancer Center

External person

Joseph A. Bilotta

  • Hoffmann-La Roche Inc.

External person

Kung Ching Chang

  • Pharmaceutical Research and Early Drug Development

External person

David C. Budd

  • Pharmaceutical Research and Early Drug Development

External person

Yingsi Chen

  • Hoffmann-La Roche Inc.

External person

Gwendolyn B. Ramsey

  • Hoffmann-La Roche Inc.

External person

Simon S. Yu

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Graham Trevitt

  • XenoGesis Ltd
  • Sygnature Discovery

External person

Ruben Alvarez Sanchez

  • Drug Metabolism and Pharmacokinetics

External person

Qi Wu

  • University of Texas MD Anderson Cancer Center

External person

Kevin R. Guertin

  • Hoffmann-La Roche Inc.

External person

David R. Bolin

  • Hoffmann-La Roche Inc.
  • Department of Immunology

External person

Jason Gay

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Center for Co-Clinical Trials
  • University of Texas Health Science Center at Houston

External person

Zhijun Kang

  • University of Texas MD Anderson Cancer Center

External person

Meredith Miller

  • University of Texas MD Anderson Cancer Center

External person

Terry Truitt

  • Discovery Technology

External person

Maria E. Fuentes

  • Pharmaceutical Research and Early Drug Development

External person

Nader Fotouhi

  • Hoffmann-La Roche Inc.

External person

Kuo Sen Huang

  • Hoffmann-La Roche Inc.

External person

Jill Garvey

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Lee McDermott

  • Hoffmann-La Roche Inc.

External person

Stanley J. Wertheimer

  • Hoffmann-La Roche Inc.

External person

Michael Myers

  • Hoffmann-La Roche Inc.

External person

Zachary Herrera

  • University of Texas MD Anderson Cancer Center

External person

Brett Virgin-Downey

  • University of Texas Health Science Center at Houston

External person

Kshitij Thakkar

  • Hoffmann-La Roche Inc.

External person

Cheryl Spence

  • Hoffmann-La Roche Inc.

External person